Cite
HARVARD Citation
El Raziky, M. et al. (2017). Simeprevir plus sofosbuvir for eight or 12 weeks in treatment‐naïve and treatment‐experienced hepatitis C virus genotype 4 patients with or without cirrhosis. Journal of viral hepatitis. 24 (2), pp. 102-110. [Online].